Global PDE Inhibitors for COPD Market Research Report 2026(Status and Outlook)

March 2026 | 134 pages | ID: GC6E0BE936BCEN
Bosson Research

Abstracts

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on PDE Inhibitors for COPD competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.PDE inhibitors for COPD are a class of drugs specifically targeting chronic obstructive pulmonary disease by selectively inhibiting the PDE4 isoenzyme, thereby enhancing intracellular cAMP signaling to achieve anti-inflammatory effects and improved airway function. Representative compounds include Roflumilast, administered as oral tablets for long-term management of patients with moderate to severe chronic bronchitis and airflow limitation. Upstream raw materials include high-purity small-molecule intermediates such as piperazine derivatives, pyridine compounds, and amide derivatives. Major suppliers are concentrated in China, India, and Europe/USA, with leading companies such as Sun Pharmaceutical, Hetero Labs, Huahai Pharmaceutical, and Lonza providing stable raw material supply and robust synthesis capabilities.Downstream customers primarily consist of global pharmaceutical firms, generic drug manufacturers, and healthcare institutions. Finished formulations are distributed to hospitals, specialty clinics, and retail pharmacies. Key international clients include Pfizer, Eli Lilly, and AstraZeneca. Driven by the growing number of COPD patients and the increasing focus on precision medicine, demand for PDE inhibitors emphasizes safety, efficacy, and stability. This trend also encourages upstream raw material and intermediate suppliers to optimize production processes and expand capacity, supporting sustainable growth across the entire industry chain.In 2024, the global average price of PDE inhibitors for COPD is approximately USD 6.4 per unit (where "unit" refers to the smallest packaged dosage form, such as a tablet, capsule, or vial), with total sales reaching about 69.22 million units.

The global PDE Inhibitors for COPD market size was estimated at USD 443.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global PDE Inhibitors for COPD market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global PDE Inhibitors for COPD market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the PDE Inhibitors for COPD market.

Global PDE Inhibitors for COPD Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

AstraZeneca
Verona Pharma
Arcutis Biotherapeutics
Torrent Pharmaceuticals
MSN Laboratories
STADA Arzneimittel
Viatris
Zydus Cadila Healthcare

Market Segmentation (by Type)

PDE4
PDE3/4

Market Segmentation (by Application)

Hospital
Clinic
Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the PDE Inhibitors for COPD Market
Overview of the regional outlook of the PDE Inhibitors for COPD Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PDE Inhibitors for COPD Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of PDE Inhibitors for COPD, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of PDE Inhibitors for COPD
1.2 Key Market Segments
  1.2.1 PDE Inhibitors for COPD Segment by Type
  1.2.2 PDE Inhibitors for COPD Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PDE INHIBITORS FOR COPD MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global PDE Inhibitors for COPD Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global PDE Inhibitors for COPD Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PDE INHIBITORS FOR COPD MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global PDE Inhibitors for COPD Product Life Cycle
3.3 Global PDE Inhibitors for COPD Sales by Manufacturers (2020-2025)
3.4 Global PDE Inhibitors for COPD Revenue Market Share by Manufacturers (2020-2025)
3.5 PDE Inhibitors for COPD Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global PDE Inhibitors for COPD Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 PDE Inhibitors for COPD Market Competitive Situation and Trends
  3.8.1 PDE Inhibitors for COPD Market Concentration Rate
  3.8.2 Global 5 and 10 Largest PDE Inhibitors for COPD Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 PDE INHIBITORS FOR COPD INDUSTRY CHAIN ANALYSIS

4.1 PDE Inhibitors for COPD Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PDE INHIBITORS FOR COPD MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global PDE Inhibitors for COPD Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to PDE Inhibitors for COPD Market
5.7 ESG Ratings of Leading Companies

6 PDE INHIBITORS FOR COPD MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PDE Inhibitors for COPD Sales Market Share by Type (2020-2025)
6.3 Global PDE Inhibitors for COPD Market Size by Type (2020-2025)
6.4 Global PDE Inhibitors for COPD Price by Type (2020-2025)

7 PDE INHIBITORS FOR COPD MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PDE Inhibitors for COPD Market Sales by Application (2020-2025)
7.3 Global PDE Inhibitors for COPD Market Size (M USD) by Application (2020-2025)
7.4 Global PDE Inhibitors for COPD Sales Growth Rate by Application (2020-2025)

8 PDE INHIBITORS FOR COPD MARKET SALES BY REGION

8.1 Global PDE Inhibitors for COPD Sales by Region
  8.1.1 Global PDE Inhibitors for COPD Sales by Region
  8.1.2 Global PDE Inhibitors for COPD Sales Market Share by Region
8.2 Global PDE Inhibitors for COPD Market Size by Region
  8.2.1 Global PDE Inhibitors for COPD Market Size by Region
  8.2.2 Global PDE Inhibitors for COPD Market Size by Region
8.3 North America
  8.3.1 North America PDE Inhibitors for COPD Sales by Country
  8.3.2 North America PDE Inhibitors for COPD Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe PDE Inhibitors for COPD Sales by Country
  8.4.2 Europe PDE Inhibitors for COPD Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific PDE Inhibitors for COPD Sales by Region
  8.5.2 Asia Pacific PDE Inhibitors for COPD Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America PDE Inhibitors for COPD Sales by Country
  8.6.2 South America PDE Inhibitors for COPD Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa PDE Inhibitors for COPD Sales by Region
  8.7.2 Middle East and Africa PDE Inhibitors for COPD Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 PDE INHIBITORS FOR COPD MARKET PRODUCTION BY REGION

9.1 Global Production of PDE Inhibitors for COPD by Region(2020-2025)
9.2 Global PDE Inhibitors for COPD Revenue Market Share by Region (2020-2025)
9.3 Global PDE Inhibitors for COPD Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America PDE Inhibitors for COPD Production
  9.4.1 North America PDE Inhibitors for COPD Production Growth Rate (2020-2025)
  9.4.2 North America PDE Inhibitors for COPD Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe PDE Inhibitors for COPD Production
  9.5.1 Europe PDE Inhibitors for COPD Production Growth Rate (2020-2025)
  9.5.2 Europe PDE Inhibitors for COPD Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan PDE Inhibitors for COPD Production (2020-2025)
  9.6.1 Japan PDE Inhibitors for COPD Production Growth Rate (2020-2025)
  9.6.2 Japan PDE Inhibitors for COPD Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China PDE Inhibitors for COPD Production (2020-2025)
  9.7.1 China PDE Inhibitors for COPD Production Growth Rate (2020-2025)
  9.7.2 China PDE Inhibitors for COPD Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 AstraZeneca
  10.1.1 AstraZeneca Basic Information
  10.1.2 AstraZeneca PDE Inhibitors for COPD Product Overview
  10.1.3 AstraZeneca PDE Inhibitors for COPD Product Market Performance
  10.1.4 AstraZeneca Business Overview
  10.1.5 AstraZeneca SWOT Analysis
  10.1.6 AstraZeneca Recent Developments
10.2 Verona Pharma
  10.2.1 Verona Pharma Basic Information
  10.2.2 Verona Pharma PDE Inhibitors for COPD Product Overview
  10.2.3 Verona Pharma PDE Inhibitors for COPD Product Market Performance
  10.2.4 Verona Pharma Business Overview
  10.2.5 Verona Pharma SWOT Analysis
  10.2.6 Verona Pharma Recent Developments
10.3 Arcutis Biotherapeutics
  10.3.1 Arcutis Biotherapeutics Basic Information
  10.3.2 Arcutis Biotherapeutics PDE Inhibitors for COPD Product Overview
  10.3.3 Arcutis Biotherapeutics PDE Inhibitors for COPD Product Market Performance
  10.3.4 Arcutis Biotherapeutics Business Overview
  10.3.5 Arcutis Biotherapeutics SWOT Analysis
  10.3.6 Arcutis Biotherapeutics Recent Developments
10.4 Torrent Pharmaceuticals
  10.4.1 Torrent Pharmaceuticals Basic Information
  10.4.2 Torrent Pharmaceuticals PDE Inhibitors for COPD Product Overview
  10.4.3 Torrent Pharmaceuticals PDE Inhibitors for COPD Product Market Performance
  10.4.4 Torrent Pharmaceuticals Business Overview
  10.4.5 Torrent Pharmaceuticals Recent Developments
10.5 MSN Laboratories
  10.5.1 MSN Laboratories Basic Information
  10.5.2 MSN Laboratories PDE Inhibitors for COPD Product Overview
  10.5.3 MSN Laboratories PDE Inhibitors for COPD Product Market Performance
  10.5.4 MSN Laboratories Business Overview
  10.5.5 MSN Laboratories Recent Developments
10.6 STADA Arzneimittel
  10.6.1 STADA Arzneimittel Basic Information
  10.6.2 STADA Arzneimittel PDE Inhibitors for COPD Product Overview
  10.6.3 STADA Arzneimittel PDE Inhibitors for COPD Product Market Performance
  10.6.4 STADA Arzneimittel Business Overview
  10.6.5 STADA Arzneimittel Recent Developments
10.7 Viatris
  10.7.1 Viatris Basic Information
  10.7.2 Viatris PDE Inhibitors for COPD Product Overview
  10.7.3 Viatris PDE Inhibitors for COPD Product Market Performance
  10.7.4 Viatris Business Overview
  10.7.5 Viatris Recent Developments
10.8 Zydus Cadila Healthcare
  10.8.1 Zydus Cadila Healthcare Basic Information
  10.8.2 Zydus Cadila Healthcare PDE Inhibitors for COPD Product Overview
  10.8.3 Zydus Cadila Healthcare PDE Inhibitors for COPD Product Market Performance
  10.8.4 Zydus Cadila Healthcare Business Overview
  10.8.5 Zydus Cadila Healthcare Recent Developments

11 PDE INHIBITORS FOR COPD MARKET FORECAST BY REGION

11.1 Global PDE Inhibitors for COPD Market Size Forecast
11.2 Global PDE Inhibitors for COPD Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe PDE Inhibitors for COPD Market Size Forecast by Country
  11.2.3 Asia Pacific PDE Inhibitors for COPD Market Size Forecast by Region
  11.2.4 South America PDE Inhibitors for COPD Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of PDE Inhibitors for COPD by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global PDE Inhibitors for COPD Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of PDE Inhibitors for COPD by Type (2026-2035)
  12.1.2 Global PDE Inhibitors for COPD Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of PDE Inhibitors for COPD by Type (2026-2035)
12.2 Global PDE Inhibitors for COPD Market Forecast by Application (2026-2035)
  12.2.1 Global PDE Inhibitors for COPD Sales (K MT) Forecast by Application
  12.2.2 Global PDE Inhibitors for COPD Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global PDE Inhibitors for COPD Market Size by Type (M USD)
Table 4. Global PDE Inhibitors for COPD Market Size by Application
Table 5. PDE Inhibitors for COPD Market Size Comparison by Region (M USD)
Table 6. Global PDE Inhibitors for COPD Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global PDE Inhibitors for COPD Sales Market Share by Manufacturers (2020-2025)
Table 8. Global PDE Inhibitors for COPD Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global PDE Inhibitors for COPD Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PDE Inhibitors for COPD as of 2025)
Table 11. Global Market PDE Inhibitors for COPD Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global PDE Inhibitors for COPD Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PDE Inhibitors for COPD Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global PDE Inhibitors for COPD Sales by Type (K MT)
Table 27. Global PDE Inhibitors for COPD Market Size by Type (M USD)
Table 28. Global PDE Inhibitors for COPD Sales (K MT) by Type (2020-2025)
Table 29. Global PDE Inhibitors for COPD Sales Market Share by Type (2020-2025)
Table 30. Global PDE Inhibitors for COPD Market Size (M USD) by Type (2020-2025)
Table 31. Global PDE Inhibitors for COPD Market Share by Type (2020-2025)
Table 32. Global PDE Inhibitors for COPD Price (USD/KG) by Type (2020-2025)
Table 33. Global PDE Inhibitors for COPD Sales (K MT) by Application
Table 34. Global PDE Inhibitors for COPD Market Size by Application
Table 35. Global PDE Inhibitors for COPD Sales by Application (2020-2025) & (K MT)
Table 36. Global PDE Inhibitors for COPD Sales Market Share by Application (2020-2025)
Table 37. Global PDE Inhibitors for COPD Market Size by Application (2020-2025) & (M USD)
Table 38. Global PDE Inhibitors for COPD Market Share by Application (2020-2025)
Table 39. Global PDE Inhibitors for COPD Sales Growth Rate by Application (2020-2025)
Table 40. Global PDE Inhibitors for COPD Sales by Region (2020-2025) & (K MT)
Table 41. Global PDE Inhibitors for COPD Sales Market Share by Region (2020-2025)
Table 42. Global PDE Inhibitors for COPD Market Size by Region (2020-2025) & (M USD)
Table 43. Global PDE Inhibitors for COPD Market Size by Region (2020-2025)
Table 44. North America PDE Inhibitors for COPD Sales by Country (2020-2025) & (K MT)
Table 45. North America PDE Inhibitors for COPD Market Size by Country (2020-2025) & (M USD)
Table 46. Europe PDE Inhibitors for COPD Sales by Country (2020-2025) & (K MT)
Table 47. Europe PDE Inhibitors for COPD Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific PDE Inhibitors for COPD Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific PDE Inhibitors for COPD Market Size by Region (2020-2025) & (M USD)
Table 50. South America PDE Inhibitors for COPD Sales by Country (2020-2025) & (K MT)
Table 51. South America PDE Inhibitors for COPD Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa PDE Inhibitors for COPD Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa PDE Inhibitors for COPD Market Size by Region (2020-2025) & (M USD)
Table 54. Global PDE Inhibitors for COPD Production (K MT) by Region(2020-2025)
Table 55. Global PDE Inhibitors for COPD Revenue (US$ Million) by Region (2020-2025)
Table 56. Global PDE Inhibitors for COPD Revenue Market Share by Region (2020-2025)
Table 57. Global PDE Inhibitors for COPD Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America PDE Inhibitors for COPD Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe PDE Inhibitors for COPD Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan PDE Inhibitors for COPD Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China PDE Inhibitors for COPD Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. AstraZeneca Basic Information
Table 63. AstraZeneca PDE Inhibitors for COPD Product Overview
Table 64. AstraZeneca PDE Inhibitors for COPD Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca SWOT Analysis
Table 67. AstraZeneca Recent Developments
Table 68. Verona Pharma Basic Information
Table 69. Verona Pharma PDE Inhibitors for COPD Product Overview
Table 70. Verona Pharma PDE Inhibitors for COPD Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Verona Pharma Business Overview
Table 72. Verona Pharma SWOT Analysis
Table 73. Verona Pharma Recent Developments
Table 74. Arcutis Biotherapeutics Basic Information
Table 75. Arcutis Biotherapeutics PDE Inhibitors for COPD Product Overview
Table 76. Arcutis Biotherapeutics PDE Inhibitors for COPD Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Arcutis Biotherapeutics Business Overview
Table 78. Arcutis Biotherapeutics SWOT Analysis
Table 79. Arcutis Biotherapeutics Recent Developments
Table 80. Torrent Pharmaceuticals Basic Information
Table 81. Torrent Pharmaceuticals PDE Inhibitors for COPD Product Overview
Table 82. Torrent Pharmaceuticals PDE Inhibitors for COPD Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Torrent Pharmaceuticals Business Overview
Table 84. Torrent Pharmaceuticals Recent Developments
Table 85. MSN Laboratories Basic Information
Table 86. MSN Laboratories PDE Inhibitors for COPD Product Overview
Table 87. MSN Laboratories PDE Inhibitors for COPD Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. MSN Laboratories Business Overview
Table 89. MSN Laboratories Recent Developments
Table 90. STADA Arzneimittel Basic Information
Table 91. STADA Arzneimittel PDE Inhibitors for COPD Product Overview
Table 92. STADA Arzneimittel PDE Inhibitors for COPD Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. STADA Arzneimittel Business Overview
Table 94. STADA Arzneimittel Recent Developments
Table 95. Viatris Basic Information
Table 96. Viatris PDE Inhibitors for COPD Product Overview
Table 97. Viatris PDE Inhibitors for COPD Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Viatris Business Overview
Table 99. Viatris Recent Developments
Table 100. Zydus Cadila Healthcare Basic Information
Table 101. Zydus Cadila Healthcare PDE Inhibitors for COPD Product Overview
Table 102. Zydus Cadila Healthcare PDE Inhibitors for COPD Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Zydus Cadila Healthcare Business Overview
Table 104. Zydus Cadila Healthcare Recent Developments
Table 105. Global PDE Inhibitors for COPD Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global PDE Inhibitors for COPD Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America PDE Inhibitors for COPD Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America PDE Inhibitors for COPD Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe PDE Inhibitors for COPD Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe PDE Inhibitors for COPD Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific PDE Inhibitors for COPD Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific PDE Inhibitors for COPD Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America PDE Inhibitors for COPD Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America PDE Inhibitors for COPD Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa PDE Inhibitors for COPD Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa PDE Inhibitors for COPD Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global PDE Inhibitors for COPD Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global PDE Inhibitors for COPD Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global PDE Inhibitors for COPD Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global PDE Inhibitors for COPD Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global PDE Inhibitors for COPD Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of PDE Inhibitors for COPD
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PDE Inhibitors for COPD Market Size (M USD), 2025-2035
Figure 5. Global PDE Inhibitors for COPD Market Size (M USD) (2020-2035)
Figure 6. Global PDE Inhibitors for COPD Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PDE Inhibitors for COPD Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global PDE Inhibitors for COPD Product Life Cycle
Figure 13. PDE Inhibitors for COPD Sales Share by Manufacturers in 2025
Figure 14. Global PDE Inhibitors for COPD Revenue Share by Manufacturers in 2025
Figure 15. PDE Inhibitors for COPD Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market PDE Inhibitors for COPD Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by PDE Inhibitors for COPD Revenue in 2025
Figure 18. Industry Chain Map of PDE Inhibitors for COPD
Figure 19. Global PDE Inhibitors for COPD Market PEST Analysis
Figure 20. Global PDE Inhibitors for COPD Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global PDE Inhibitors for COPD Market Share by Type
Figure 27. Sales Market Share of PDE Inhibitors for COPD by Type (2020-2025)
Figure 28. Sales Market Share of PDE Inhibitors for COPD by Type in 2025
Figure 29. Market Share of PDE Inhibitors for COPD by Type (2020-2025)
Figure 30. Market Share of PDE Inhibitors for COPD by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global PDE Inhibitors for COPD Market Share by Application
Figure 33. Global PDE Inhibitors for COPD Sales Market Share by Application (2020-2025)
Figure 34. Global PDE Inhibitors for COPD Sales Market Share by Application in 2025
Figure 35. Global PDE Inhibitors for COPD Market Share by Application (2020-2025)
Figure 36. Global PDE Inhibitors for COPD Market Share by Application in 2025
Figure 37. Global PDE Inhibitors for COPD Sales Growth Rate by Application (2020-2025)
Figure 38. Global PDE Inhibitors for COPD Sales Market Share by Region (2020-2025)
Figure 39. Global PDE Inhibitors for COPD Market Size by Region (2020-2025)
Figure 40. North America PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America PDE Inhibitors for COPD Sales Market Share by Country in 2024
Figure 43. North America PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America PDE Inhibitors for COPD Market Size by Country in 2024
Figure 45. U.S. PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada PDE Inhibitors for COPD Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada PDE Inhibitors for COPD Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico PDE Inhibitors for COPD Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico PDE Inhibitors for COPD Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe PDE Inhibitors for COPD Sales Market Share by Country in 2024
Figure 53. Europe PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe PDE Inhibitors for COPD Market Size by Country in 2024
Figure 55. Germany PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific PDE Inhibitors for COPD Sales and Growth Rate (K MT)
Figure 66. Asia Pacific PDE Inhibitors for COPD Sales Market Share by Region in 2024
Figure 67. Asia Pacific PDE Inhibitors for COPD Market Size by Region in 2024
Figure 68. China PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America PDE Inhibitors for COPD Sales and Growth Rate (K MT)
Figure 79. South America PDE Inhibitors for COPD Sales Market Share by Country in 2024
Figure 80. South America PDE Inhibitors for COPD Market Size and Growth Rate (M USD)
Figure 81. South America PDE Inhibitors for COPD Market Size by Country in 2024
Figure 82. Brazil PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa PDE Inhibitors for COPD Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa PDE Inhibitors for COPD Sales Market Share by Region in 2024
Figure 90. Middle East and Africa PDE Inhibitors for COPD Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa PDE Inhibitors for COPD Market Size by Region in 2024
Figure 92. Saudi Arabia PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa PDE Inhibitors for COPD Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa PDE Inhibitors for COPD Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global PDE Inhibitors for COPD Production Market Share by Region (2020-2025)
Figure 103. North America PDE Inhibitors for COPD Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe PDE Inhibitors for COPD Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan PDE Inhibitors for COPD Production (K MT) Growth Rate (2020-2025)
Figure 106. China PDE Inhibitors for COPD Production (K MT) Growth Rate (2020-2025)
Figure 107. Global PDE Inhibitors for COPD Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global PDE Inhibitors for COPD Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global PDE Inhibitors for COPD Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global PDE Inhibitors for COPD Market Share Forecast by Type (2026-2035)
Figure 111. Global PDE Inhibitors for COPD Sales Forecast by Application (2026-2035)
Figure 112. Global PDE Inhibitors for COPD Market Share Forecast by Application (2026-2035)